The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trial (Q28256092)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trial	scientific article

Statements

scholarly article

0 references

The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trial (English)

0 references

lopinavir/ritonavir

0 references

1 reference

ChEBI release 2020-05-28

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Christine Katlama

8

object named as

Christine Katlama

0 references

Schlomo Staszewski

6

object named as

Schlomo Staszewski

0 references

1

object named as

Joseph Eron

0 references

3

object named as

Joseph Gathe

0 references

author name string

Patrick Yeni

2

0 references

Vicente Estrada

4

0 references

Edwin DeJesus

5

0 references

Philip Lackey

7

0 references

Benjamin Young

9

0 references

Linda Yau

10

0 references

Denise Sutherland-Phillips

11

0 references

Paul Wannamaker

12

0 references

Cindy Vavro

13

0 references

Lisa Patel

14

0 references

Jane Yeo

15

0 references

Mark Shaefer

16

0 references

language of work or name

0 references

publication date

5 August 2006

0 references

0 references

368

0 references

9534

0 references

476-82

0 references

Decline in the AIDS and death rates in the EuroSIDA study: an observational study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969155-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969155-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Lopinavir-ritonavir versus nelfinavir for the initial treatment of HIV infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969155-1

7 January 2021

based on heuristic

inferred from DOI database lookup

SOLO: 48-week efficacy and safety comparison of once-daily fosamprenavir /ritonavir versus twice-daily nelfinavir in naive HIV-1-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969155-1

7 January 2021

based on heuristic

inferred from DOI database lookup

GW433908/ritonavir once daily in antiretroviral therapy-naive HIV-infected patients: absence of protease resistance at 48 weeks

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969155-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Baseline HIV-1 RNA level and CD4 cell count predict time to loss of virologic response to nelfinavir, but not lopinavir/ritonavir, in antiretroviral therapy-naive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969155-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969155-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969155-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Triple-nucleoside regimens versus efavirenz-containing regimens for the initial treatment of HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969155-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA Panel

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969155-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence of resistance in a double-blind study comparing lopinavir/ritonavir plus stavudine and lamivudine to nelfinavir plus stavudine and lamivudine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969155-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Hypersensitivity reactions during therapy with the nucleoside reverse transcriptase inhibitor abacavir

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969155-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(06)69155-1

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28256092&oldid=1980074732"